2-[4-(1,3,4-oxadiazol-2-yl)phenyl]acetic acid
Structure Info
- Chemspace ID
- CSSB00010429991 (In-Stock Building Blocks)
- CAS
- 52787-22-1
- MFCD
- MFCD24486309
- IUPAC Name
- 2-[4-(1,3,4-oxadiazol-2-yl)phenyl]acetic acid
- Mol formula
- C10H8N2O3
- Mol weight
- 204 Da
- Catalog Number(s)
- AG028E52, AR028EU2, BB4LS-EN300-7549863, BBLS00010429991, BBV-45233288, BD02604974, BL50606, CSC010429991, EN300-7549863, FCH1796257, ST028FLU, SY352239, TX028FAQ, Y3154985, ZXC392352, bbls00010429991
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.62
- Heavy atoms count
- 15
- Rotatable bond count
- 3
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.1
- Polar surface area (Å)
- 76
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of 2-[4-(1,3,4-oxadiazol-2-yl)phenyl]acetic acid (C10H8N2O3) - CSSB00010429991](/st/structure/200/3f699c3ae9aebd3936e318cef5b1c3b5/OC%2528%253DO%2529CC1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DCO1.png "C10H8N2O3")
- Zoom the structure
- CSSB00010429991
Items Overall 37 items from 6 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS US | 2 days | United States To: | 95 | 50 umol | 85.14 | |
| BB4LS US | 2 days | United States To: | 95 | 100 umol | 116.11 | |
| BB4LS US | 2 days | United States To: | 95 | 200 umol | 161.67 | |
| BB4LS US | 2 days | United States To: | 95 | 300 umol | 198.00 | |
| BB4LS US | 2 days | United States To: | 95 | 500 umol | 259.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 173.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 257.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 367.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 579.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 743.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 2.5 g | 1,454.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 5 g | 2,152.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 10 g | 3,191.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 50 mg | 173.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 100 mg | 257.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 250 mg | 367.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 500 mg | 579.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 1 g | 743.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 2.5 g | 1,454.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 173.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 257.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 367.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 579.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 1 g | 743.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 2.5 g | 1,454.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 5 g | 2,152.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 50 umol | 85.14 | |
| BB4LS EU | 7 days | Germany To: | 95 | 100 umol | 116.11 | |
| BB4LS EU | 7 days | Germany To: | 95 | 200 umol | 161.67 | |
| BB4LS EU | 7 days | Germany To: | 95 | 300 umol | 198.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 500 umol | 259.00 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 50 mg | 255.20 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 100 mg | 350.90 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 250 mg | 478.50 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 500 mg | 723.80 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 1 g | 914.10 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 2.5 g | 1,736.90 | |
Description: 2-[4-(1,3,4-oxadiazol-2-yl)phenyl]acetic acid; CAS: 52787-22-1 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of methyl 2-[4-(1,3,4-oxadiazol-2-yl)phenyl]acetate - CSSB01780557714](/st/structure/200/d6cf469f35095885d84b6ec76eff9d3b/COC%2528%253DO%2529CC1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DCO1.png)
![Chemical structure of ethyl 2-[4-(1,3,4-oxadiazol-2-yl)phenyl]acetate - CSSB21291565439](/st/structure/200/25f6e139b44cb1c4a8ea20f296453938/CCOC%2528%253DO%2529CC1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DCO1.png)
Similarity Analogs
![Chemical structure of 2-[4-(1,3,4-oxadiazol-2-yl)phenyl]acetamide - CSSB21043422049](/st/structure/200/42d977fcb88f179b1a594902c16067ae/NC%2528%253DO%2529CC1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DCO1.png)
![Chemical structure of 2-[4-(1,3-oxazol-2-yl)phenyl]acetic acid - CSSB00020934417](/st/structure/200/4c5f5187c7c932101cf77a460f1e25f2/OC%2528%253DO%2529CC1%253DCC%253DC%2528C%253DC1%2529C1%253DNC%253DCO1.png)
![Chemical structure of N-methyl-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]acetamide - CSSB21043407616](/st/structure/200/0f5bf3f6be5fcaf6d1b07c2a54c4dac7/CNC%2528%253DO%2529CC1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DCO1.png)
![Chemical structure of N,N-dimethyl-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]acetamide - CSSB21043422050](/st/structure/200/ae41e84aef6d6df700a373225943224b/CN%2528C%2529C%2528%253DO%2529CC1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DCO1.png)
![Chemical structure of 2-[4-(4-methyl-1,3-oxazol-2-yl)phenyl]acetic acid - CSSB00021382145](/st/structure/200/651e4f4e8ac0d0fece86a8f3bcdc15c3/CC1%253DCOC%2528%253DN1%2529C1%253DCC%253DC%2528CC%2528O%2529%253DO%2529C%253DC1.png)
